Occuity

Occuity builds non-invasive optical devices for health diagnostics.

Reading, UK—Founded 2019—Website

£5.2MTotal raised

Occuity develops non-invasive optical instruments that use the eye to screen for and monitor chronic conditions. Its diagnostic technology aims to transform healthcare delivery through ocular screening.

Team

Dan Daly

CEO and Co-founder

Daniele De Iuliis

Design Director

Toby Hicks

Robin Taylor

Co-founder

Robin brings engineering and technical leadership experience from roles at Occuity Limited, Lein Applied Diagnostics, and Aston University.

Investors

Series A19 October 2021
£2.9M
Seedrs
Seed22 October 2020
£1.0M
Angel Investment NetworkLead

Funding history

Seed11 December 2023

£1.3M

Occuity has raised £1.3m in a convertible loan note round to fund product development and commercial preparation.

The financing was supported by the company network of angel investors.

Series A19 October 2021

£2.9M

Occuity raises £2.9m in Series A funding on Seedrs to develop optical glucose meters

The Berkshire-based medical technology start-up secured the financing from over 850 investors on the crowdfunding platform.

Seed22 October 2020

£1.0M

Occuity raises over £1m in seed funding led by Angel Investment Network to advance medical diagnostic devices

The Reading-based healthcare technology company secured the financing over five months to progress product development and clinical trials.